


散光CON要戴得舒適,仲要鏡片夠穩定,真係唔易!博士倫Biotrue® ONEday散光CON幫鏡片搵到理想穩定區,減少鏡邊同眼皮接觸,自然超級穩定又舒適。
參考眨眼習慣3,準確調整提升穩定性
舒適體驗all day long4
深散光275度都有#
180°軸位有齊^
#只限球面度數平光至600度(每50度增加)
^散光度數175度以下
返工成日對電腦,又要睇手機,睇到眼都唔眨,眨眼次數大減5,唔怪得雙眼dry到爆!博士倫Biotrue® ONEday獨有Surface Active Technology™,大大減低淚水揮發,keep住16個鐘雙眼都水潤舒服。
眼睛水潤舒適
Keep住水潤接近99%
有害紫外光線 No Way!
有老花望近再望遠就眼花花?博士倫Biotrue® ONEday漸進CON有全對焦光學設計,鏡片度數由外至內漸進改變,fit晒瞳孔望遠放大,望近縮細嘅生理反應,望近中遠都清晰自然無問題!
視線都可以 stay younger
工作更得心應手%
唔使又戴又除眼鏡
咁麻煩
References: 1. Twenty two subjects participated in a randomized, double-masked, contralateral eye study to evaluate water loss of Biotrue® ONEday and 1-Day Acuvue® Moist contact lenses. After 4, 8, 12, and 16 hours of wear, lenses were removed and immediately weighed (wet weight). The lenses were then completely dried and reweighed (dry weight). The percent water loss was then calculated for each lens from the wet and dry weights. 2. US Patent 8,197,841 (2012): Lindhardt, Salamone, Ammon and Hook. 3. Data on File 2016. Bausch & Lomb Incorporated. Pre-lens tear stability comparison. 12 existing contact lens wearers participated in study 1 and 11 participated in study 2. In study 1, each subject wore 4 types of daily disposable lenses (nesofilcon A (Biotrue® ONEday), narafilcon A (1 day Acuvue® TruEye), delefilcon A (Dailies® Total 1), etafilcon A (1 day Acuvue® Moist)) in 4 separate days in random order and in study 2, each subject wore 3 types of daily disposable lenses (nesofilcon A (Biotrue® ONEday), senofilcon A (1 day Acuvue® Oasys), somofilcon A (Clariti® 1 day) ) in 3 separate days in random order. NITBUT was measured using Oculus Keratograph 5M at baseline and also after 12 hours of lens wear. Five measurements were taken and the closest 3 were averaged to obtain the mean value. NITBUT for BTOD was then compared against all 5 other brands of lenses and derived that BTOD’s NITBUT is 2 times of 3 other brands of lenses. 4. Data on file 2016. Blink Pattern Considerations during the Development of Bausch + Lomb Toric Lenses. 5. Results of an online survey with patients who completed an evaluation program for Biotrue ONEday for Astigmatism contact lenses and wore their trial lenses for ≥4 days (n=1001). Survey results include patients who strongly agreed, agreed, or slightly agreed (on a 6-point agreement scale) with the surveyed statement, with a margin of error ±1.4%.